Aashirwad Ayurveda Pharmacy India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 8.50 M
as on 03-07-2024
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 03-07-2024
- Revenue 23.69%
(FY 2022)
- Profit -1578.95%
(FY 2022)
- Ebitda -246.39%
(FY 2022)
- Net Worth 211.02%
(FY 2022)
- Total Assets 271.91%
(FY 2022)
About Aashirwad Ayurveda Pharmacy India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.50 M.
The company currently has active open charges totaling ₹2.00 Cr.
Ramkumar Kutty and Elattuvalappil Lakshmi serve as directors at the Company.
- CIN/LLPIN
U74999TZ2018PTC031182
- Company No.
031182
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Aashirwad Ayurveda Pharmacy India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Elattuvalappil Lakshmi  | Director | 20-Dec-2021 | Current |
| Ramkumar Kutty | Director | 22-May-2020 | Current |
Financial Performance and Corporate Structure Insights of Aashirwad Ayurveda Pharmacy India.
Aashirwad Ayurveda Pharmacy India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.69% increase. The company also saw a substantial fall in profitability, with a 1578.95% decrease in profit. The company's net worth Soared by an impressive increase of 211.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aashirwad Ayurveda Pharmacy India?
In 2022, Aashirwad Ayurveda Pharmacy India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
The Arya Vaidya Pharmacy (Coimbatore) LimitedActive 76 years 8 monthsRamkumar Kutty is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 17 Jun 2022 | ₹2.00 Cr | Open |
How Many Employees Work at Aashirwad Ayurveda Pharmacy India?
Aashirwad Ayurveda Pharmacy India has a workforce of 38 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aashirwad Ayurveda Pharmacy India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aashirwad Ayurveda Pharmacy India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
